文献速递中医妇科中药与中成药合理使用

中药治疗子宫内膜异位症相关疼痛:Meta分析

Chinese Herbal Medicine, Alternative or Complementary, for Endometriosis-Associated Pain: A Meta-Analysis.
PubMed 文献 · Am J Chin Med · 2023-04-29

该系统评价纳入34项随机对照试验共3389例子宫内膜异位症相关疼痛患者,比较中药与不治疗、常规治疗或联合治疗的疗效与安全性。结果显示中药单用或联合常规治疗在缓解痛经、盆腔痛、性交痛方面有获益,且潮热、不规则阴道出血等副作用较少。

要点

  • 中药单用或联合常规治疗可缓解子宫内膜异位症相关疼痛。
  • 与常规治疗相比,中药联合治疗3个月经周期可改善痛经、性交痛和盆腔痛。
  • 中药治疗潮热和不规则阴道出血发生率低于常规治疗。

核心结论

  • 中药单用或联合常规治疗在缓解子宫内膜异位症相关疼痛方面有获益,且副作用少于传统治疗。

研究设计与样本

  • 纳入34项比较中药与其他治疗子宫内膜异位症相关疼痛的随机对照试验,共3389例参与者。

主要发现

  • 与不治疗相比,中药治疗3个月结束时痛经有统计学显著合并获益,且效果持续至治疗后3个月,但未持续至9个月。
  • 与常规治疗相比,治疗3个月结束时盆腔痛水平有显著差异,潮热和不规则阴道出血发生率更低,但治疗结束后无显著差异。
  • 中药联合常规治疗与单用常规治疗相比,治疗3个月周期后痛经、性交痛和盆腔痛显著降低,治疗4个月周期后痛经显著降低且潮热发生率更低。

关键数值与推荐

  • 连续变量采用加权均数差及95%CI进行Meta分析,二分类变量采用合并RR及95%CI。

临床怎么用

  • 对于子宫内膜异位症相关疼痛患者,可考虑中药单用或联合常规治疗以缓解疼痛并减少激素相关副作用。

局限性

  • 原文未报告纳入研究的偏倚风险、异质性及发表偏倚等局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current medical treatments for endometriosis-associated pain (EAP) have limitations, including symptom recurrence and hormonal side effects. For this reason, it is important to elucidate any alternative or complementary treatments available, while Chinese herbal medicine (CHM) shows potential to be this treatment. This study aims to provide evidence for the efficacy and safety of CHM for EAP. Randomized control trials comparing CHM to other treatments for EAP in women with endometriosis were considered eligible, and they were searched for in Medline, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov, as well as in the Chinese databases Sino-Med and CNKI, from inception to October 2021. Numerous outcomes were put through meta-analysis using a weighted mean difference and a 95% CI, and the results of dichotomous data were presented as a pooled RR with a 95% CI. A total of 34 eligible studies with 3389 participants were included. Compared with no treatment, there was a statistically significant pooled benefit of CHM on dysmenorrhea at the end of 3-month treatment, and these effects continued for 3 months, but not 9 months, after treatment. Compared with conventional therapy, a significant difference was found in the levels of pelvic pain with a lower rate of hot flush and irregular vaginal bleeding at the end of treatment for 3 months, but not after treatment. Comparing combined treatment with CHM and conventional therapy with conventional therapy alone, significant decreases were found in dysmenorrhea, dyspareunia, and pelvic pain after a 3-month treatment cycle, and in dysmenorrhea after a 4-month treatment cycle with a lower hot flash rate. In conclusion, CHM, used alone or in combination with conventional therapies, appears to have benefits in relieving EAP with fewer side effects than traditional treatment.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Lin Y, Wu L, Zhao R, et al. Chinese Herbal Medicine, Alternative or Complementary, for Endometriosis-Associated Pain: A Meta-Analysis. Am J Chin Med. 2023. PMID: 37120704. doi:10.1142/S0192415X23500386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。